Geert Walther Nygaard
Chief Executive Officer at IBL International GmbH
Profile
Geert Walther Nygaard is currently the Co-Managing Director at IBL International GmbH.
Previously, he was the Chief Executive Officer at Glycorex Transplantation AB from 2021 to 2022, and at Epigenomics AG from 2007 to 2010.
He also served as a Director at Abbott GmbH (Germany) in 2012.
Nygaard completed his undergraduate degree at the Technical University of Denmark.
Geert Walther Nygaard active positions
Companies | Position | Start |
---|---|---|
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Chief Executive Officer | - |
Former positions of Geert Walther Nygaard
Companies | Position | End |
---|---|---|
GLYCOREX TRANSPLANTATION AB | Chief Executive Officer | 2022-12-07 |
EPIGENOMICS AG | President | 2012-09-29 |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Director/Board Member | - |
Training of Geert Walther Nygaard
Technical University of Denmark | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GLYCOREX TRANSPLANTATION AB | Health Technology |
EPIGENOMICS AG | Health Technology |
Private companies | 2 |
---|---|
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Health Technology |
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
- Stock Market
- Insiders
- Geert Walther Nygaard